Insider · CIK 0002050086

Rasbach Kyle

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

Companies

Filings

CIK

0002050086

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-17	LXEOLexeo Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+40.9K sh	—	—	40,875
2025-01-17	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+245K sh	—	—	245,250

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010